AbCellera Biologics
IPOTechnologies for faster and better antibody discovery
Vancouver, Canada · Founded 2012
- Headquarters
- Vancouver
- Employees
- 501–1000
- Founded
- 2012
- Business Model
- B2B
- Last Round
- Series BMay 2020
- Rounds
- 2
About
AbCellera is a clinical-stage biotechnology company founded in 2012 in Vancouver, Canada, by scientists who pioneered microfluidics and single-cell analysis technologies for antibody discovery. Its integrated platform has supported over 100 therapeutic antibody discovery programs with biopharma partners, and since 2023 the company has shifted focus toward advancing its own pipeline of programs in oncology, endocrine/metabolic conditions, and inflammation & autoimmunity.
Summary
AbCellera Biologics is a Biotech company based in Vancouver, Canada, founded in 2012. Its most recent funding was a Series B round in May 2020. Investors include OrbiMed, DCVC (Data Collab) and Viking Global.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...